Brief: Sprint Bioscience AB - Outcome Of Exercise Of Warrants Of To 2 Series
01/06/2020 14:58
June 1 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* SPRINT BIOSCIENCE AB - OUTCOME OF EXERCISE OF WARRANTS OF TO 2 SERIES
* SPRINT BIOSCIENCE AB - 47,031 WARRANTS USED TO SUBSCRIBE FOR SHARES, WHICH MEANS AN
EXERCISE
RATIO OF 4.38%
Source text for Eikon: ID:nWkr4ZVK6
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln